Core Laboratories N.V. (CLB): Price and Financial Metrics


Core Laboratories N.V. (CLB): $19.78

-0.77 (-3.75%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CLB POWR Grades


  • CLB scores best on the Momentum dimension, with a Momentum rank ahead of 97.54% of US stocks.
  • The strongest trend for CLB is in Stability, which has been heading up over the past 179 days.
  • CLB ranks lowest in Sentiment; there it ranks in the 5th percentile.

CLB Stock Summary

  • CLB's current price/earnings ratio is 74.88, which is higher than 90.61% of US stocks with positive earnings.
  • The price/operating cash flow metric for Core Laboratories N V is higher than 86.64% of stocks in our set with a positive cash flow.
  • Over the past twelve months, CLB has reported earnings growth of -157.87%, putting it ahead of merely 12.1% of US stocks in our set.
  • Stocks that are quantitatively similar to CLB, based on their financial statements, market capitalization, and price volatility, are BLNK, LOTZ, CDMO, SAND, and INDO.
  • Visit CLB's SEC page to see the company's official filings. To visit the company's web site, go to www.corelab.com.

CLB Valuation Summary

  • In comparison to the median Energy stock, CLB's EV/EBIT ratio is 44.9% higher, now standing at 26.3.
  • Over the past 243 months, CLB's price/sales ratio has gone up 1.5.
  • Over the past 243 months, CLB's EV/EBIT ratio has gone up 13.

Below are key valuation metrics over time for CLB.

Stock Date P/S P/B P/E EV/EBIT
CLB 2021-09-03 2.9 8.6 39.6 26.3
CLB 2021-09-02 2.9 8.7 39.9 26.4
CLB 2021-09-01 2.9 8.5 38.9 25.9
CLB 2021-08-31 2.9 8.5 39.1 26.0
CLB 2021-08-30 2.9 8.7 39.9 26.4
CLB 2021-08-27 3.0 8.9 41.0 27.1

CLB Growth Metrics

    The 4 year net cashflow from operations growth rate now stands at -53.46%.
  • The 4 year price growth rate now stands at -88.42%.
  • The 2 year revenue growth rate now stands at -3.07%.
Over the past 70 months, CLB's revenue has gone down $267,272,000.

The table below shows CLB's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 470.252 36.579 19.727
2021-09-30 458.862 17.579 30.576
2021-06-30 446.259 26.32 32.665
2021-03-31 443.25 43.83 18.889
2020-12-31 487.267 57.868 -97.637
2020-09-30 530.296 91.016 -100.844

CLB's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CLB has a Quality Grade of B, ranking ahead of 82.88% of graded US stocks.
  • CLB's asset turnover comes in at 0.785 -- ranking 22nd of 136 Petroleum and Natural Gas stocks.
  • CKX, RES, and NESR are the stocks whose asset turnover ratios are most correlated with CLB.

The table below shows CLB's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.785 0.218 0.083
2021-06-30 0.762 0.223 0.090
2021-03-31 0.752 0.224 0.064
2020-12-31 0.805 0.231 -0.109
2020-09-30 0.808 0.237 -0.107
2020-06-30 0.847 0.248 -0.076

CLB Price Target

For more insight on analysts targets of CLB, see our CLB price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $30.85 Average Broker Recommendation 1.95 (Hold)

CLB Stock Price Chart Interactive Chart >

Price chart for CLB

CLB Price/Volume Stats

Current price $19.78 52-week high $40.97
Prev. close $20.55 52-week low $18.41
Day low $19.77 Volume 21,840
Day high $20.43 Avg. volume 501,223
50-day MA $25.12 Dividend yield 0.19%
200-day MA $26.93 Market Cap 915.97M

Core Laboratories N.V. (CLB) Company Bio


Core Laboratories provides proprietary and patented reservoir description, production enhancement, and reservoir management services used to optimize petroleum reservoir performance. The company was founded in 1936 and is based in Amsterdam, the Netherlands.


CLB Latest News Stream


Event/Time News Detail
Loading, please wait...

CLB Latest Social Stream


Loading social stream, please wait...

View Full CLB Social Stream

Latest CLB News From Around the Web

Below are the latest news stories about Core Laboratories N V that investors may wish to consider to help them evaluate CLB as an investment opportunity.

Core Labs (CLB) Q4 Earnings Meet Estimates, Revenues Surpass

Core Laboratories' (CLB) fourth-quarter earnings are on par with the consensus mark, while revenues beat estimates as a result of a strong performance in the Production Enhancement segment.

Yahoo | February 9, 2022

Capital Asset Advisory Services LLC Buys iShares Russell 3000 ETF, iShares 7-10 Year Treasury ...

Investment company Capital Asset Advisory Services LLC (Current Portfolio) buys iShares Russell 3000 ETF, iShares 7-10 Year Treasury Bond ETF, Vanguard Short-Term Inflation-Protected Securities, Vanguard Ultra-Short Bond ETF, iShares Short Treasury Bond ETF, sells Vanguard Total Bond Market ETF, iShares iBoxx USD High Yield Corporate Bond ETF, SPDR Dow Jones Industrial Average ETF, Utilities Select Sector SPDR ETF, SPDR MSCI USA StrategicFactors SM ETF during the 3-months ended 2021Q4, according

Yahoo | February 4, 2022

Core Laboratories (CLB) Q4 2021 Earnings Call Transcript

Image source: The Motley Fool. Core Laboratories (NYSE: CLB)Q4 2021 Earnings CallFeb 03, 2022, 8:30 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood morning, and welcome to the Core Laboratories fourth quarter 2021 earnings conference call.

Yahoo | February 4, 2022

Core Laboratories (CLB) Meets Q4 Earnings Estimates

Core Laboratories (CLB) delivered earnings and revenue surprises of 0% and 1.52%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 2, 2022

CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2021 RESULTS FROM CONTINUING OPERATIONS:

Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported fourth quarter 2021 revenue of $125,100,000. Core's operating income was $14,200,000, yielding operating margins of 11%, with earnings per diluted share ("EPS") of $0.06, all in accordance with U.S. generally accepted accounting principles ("GAAP"). EPS, ex-items, a non-GAAP financial measure, was $0.20. Income tax expense in the fourth quarter of 2021 was elevated primarily d

Yahoo | February 2, 2022

Read More 'CLB' Stories Here

CLB Price Returns

1-mo -29.81%
3-mo -38.98%
6-mo -11.27%
1-year -49.14%
3-year -61.33%
5-year -78.85%
YTD -11.27%
2021 -15.73%
2020 -29.05%
2019 -34.35%
2018 -44.49%
2017 -6.83%

CLB Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CLB Dividend History

Continue Researching CLB

Want to see what other sources are saying about Core Laboratories N V's financials and stock price? Try the links below:

Core Laboratories N V (CLB) Stock Price | Nasdaq
Core Laboratories N V (CLB) Stock Quote, History and News - Yahoo Finance
Core Laboratories N V (CLB) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8133 seconds.